Comparative analysis of enzymatically produced novel linear DNA constructs with plasmids for use as DNA vaccines. - Wikidata - awgldk - TriplyDB

Comparative analysis of enzymatically produced novel linear DNA constructs with plasmids for use as DNA vaccines.

Comparative analysis of enzymatically produced novel linear DNA constructs with plasmids for use as DNA vaccines.

http://www.wikidata.org/entity/Q33847809

about

A Comparison of Red Fluorescent Proteins to Model DNA Vaccine Expression by Whole Animal In Vivo Imaging.Novel synthetic plasmid and Doggybone DNA vaccines induce neutralizing antibodies and provide protection from lethal influenza challenge in mice DNA Vaccines Encoding Antigen Targeted to MHC Class II Induce Influenza-Specific CD8(+) T Cell Responses, Enabling Faster Resolution of Influenza Disease.Current status of gene therapy for breast cancer: progress and challenges.Electroporation-enhanced delivery of nucleic acid vaccines.Resolving systematic errors in widely used enhancer activity assays in human cells.Linear doggybone DNA vaccine induces similar immunological responses to conventional plasmid DNA independently of immune recognition by TLR9 in a pre-clinical model.New Vaccine Technologies to Combat Outbreak Situations

P2860

Q35668694-32484A2E-DD59-4119-BB0E-792B8F5986E0 Q36255758-6E49142B-727E-4A9B-9C8F-BD0B5C0360E5 Q37194981-065EE6F2-D2BF-4FB4-A3CB-72A3F70CA24F Q38270806-94E0F6EE-B74C-4AE3-88E8-D87069275552 Q38285418-4613F93A-8736-4E4D-B9B0-4835EBD7C8B2 Q48095641-69B04DC0-34D3-4C2D-8EE0-A295A58A917A Q50058150-BC75FA2E-70E5-4143-8122-7CB58133770A Q57072744-156326CF-7A2A-4252-80C7-727A6731867B

P2860

Comparative analysis of enzymatically produced novel linear DNA constructs with plasmids for use as DNA vaccines.

http://www.wikidata.org/entity/Q33847809

description

2014 nî lūn-bûn

@nan

2014 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Comparative analysis of enzyma ...... smids for use as DNA vaccines.

@ast

Comparative analysis of enzyma ...... smids for use as DNA vaccines.

@en

type

label

Comparative analysis of enzyma ...... smids for use as DNA vaccines.

@ast

Comparative analysis of enzyma ...... smids for use as DNA vaccines.

@en

prefLabel

Comparative analysis of enzyma ...... smids for use as DNA vaccines.

@ast

Comparative analysis of enzyma ...... smids for use as DNA vaccines.

@en

P1433

Q33847809-DA1CDA5C-D706-4824-ADCE-4D54CD0B2CBE

P1476

Q33847809-39D0AC08-CFE8-476B-8C0D-F685C81D96DF

P2093

Q33847809-27E3E83E-AE9E-4C82-ABDB-07FE929F6296

Q33847809-2EFAFFAA-403F-4C7D-A98C-71DFF60C849F

Q33847809-467F7F34-F6AD-426E-B9F7-406EA0471AD2

Q33847809-9EA6F567-34EF-4F73-AC65-1079078CF418

Q33847809-C805EEE4-2E0A-4600-A3F4-5A7CB6DC5AC0

Q33847809-F8369EBD-621D-4A68-A10F-615F78B7EC42

P2860

Q33847809-027F43D3-938A-44B5-B056-7D9F968E4A97

Q33847809-03EB75C7-8F98-42EC-B25D-E9A12E700EAB

Q33847809-17EBDDCC-1289-4460-8CF1-0DAD99C32C81

Q33847809-2058020B-79F4-4FA0-AF8D-3A82A46C5CCF

Q33847809-2277D6F4-0558-430A-831F-B0192983BD8A

Q33847809-47A53A7B-74AB-4DCD-A4FA-C2FA5CF27B6B

Q33847809-523D95C5-C288-45F7-8155-F9C7ED354755

Q33847809-554FF6AF-A5D9-46B9-8F22-98E7716A4AB2

Q33847809-5907CD34-B86C-47A0-904C-84E146271053

Q33847809-59AE7750-E3D1-4E5C-8888-E3FA59C0BFDF

P2888

Q33847809-07851141-9730-4905-93D9-16B59C5D16FD

P304

Q33847809-13016A75-FDEF-4C6E-9DE5-90EA5F254DC1

P31

Q33847809-98D839EE-B215-4D64-87A0-6A0C6A420F41

P356

Q33847809-E57E5DE8-2E56-48A0-8B37-C5C4C176C11A

P433

Q33847809-A265692B-4342-409A-9DC9-B946CFE8B27A

P478

Q33847809-02ADBE99-5723-49DB-A125-FBF0C54CAE22

P50

Q33847809-EBBAA47E-29DE-4F06-99AE-FA2ED39CED28

P577

Q33847809-4297FD7F-04E5-4071-9A60-F44709483A9E

P5875

Q33847809-370FF8F4-7CB6-4146-9887-8A1AF7F6B02B

P698

Q33847809-050CF85E-6C66-45B2-A528-D6BFC3FFC0EF

P932

Q33847809-71EC2D03-BB18-456C-9A27-A6A5A4393C5F

P356

P1433

P1476

Comparative analysis of enzyma ...... smids for use as DNA vaccines.

@en

P2093

A A Walters

http://www.w3.org/2001/XMLSchema#string

E Kinnear

http://www.w3.org/2001/XMLSchema#string

J U McDonald

http://www.w3.org/2001/XMLSchema#string

L J Caproni

http://www.w3.org/2001/XMLSchema#string

N Porter

http://www.w3.org/2001/XMLSchema#string

R J Shattock

http://www.w3.org/2001/XMLSchema#string

P2860

DNA vaccines: immunology, application, and optimization*

A robust system for production of minicircle DNA vectors

Intracellular tracking of single-plasmid DNA particles after delivery by electroporation

FDA guidance on prophylactic DNA vaccines: analysis and recommendations.

Immune response induced by a linear DNA vector: influence of dose, formulation and route of injection.

Mucosal application of gp140 encoding DNA polyplexes to different tissues results in altered immunological outcomes in mice.

Intravaginal immunization using the recombinant HIV-1 clade-C trimeric envelope glycoprotein CN54gp140 formulated within lyophilized solid dosage forms

Clinical applications of DNA vaccines: current progress.

DNA vaccines: are they still just a powerful tool for the future?

Pulmonary delivery of DNA vaccine constructs using deacylated PEI elicits immune responses and protects against viral challenge infection.

P2888

P304

645-652

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/GT.2014.37

http://www.w3.org/2001/XMLSchema#string

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

21

http://www.w3.org/2001/XMLSchema#string

P50

P577

2014-05-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

262381596

http://www.w3.org/2001/XMLSchema#string

P698

24830436

http://www.w3.org/2001/XMLSchema#string

P932

4082409

http://www.w3.org/2001/XMLSchema#string